Systematic Review of Endolymphatic Sac Tumor Treatment and Outcomes.
endolymphatic sac
endolymphatic sac tumor
von Hippel-Lindau
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
17
02
2022
accepted:
02
06
2022
pubmed:
29
6
2022
medline:
23
3
2023
entrez:
28
6
2022
Statut:
ppublish
Résumé
Endolymphatic sac tumors are rare neoplasms originating in the endolymphatic sac. Current literature is limited to case reports and small case series. The objective of this study was to systematically review the literature to better describe clinical presentation, treatment options, and outcomes in endolymphatic sac tumors. PubMed, Embase, and Cochrane Library. A systematic review was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines describing human endolymphatic sac tumors. Risk of bias was assessed using a validated critical appraisal checklist for case series. Studies without inclusion of individual patient characteristics, corresponding treatments, and outcomes were excluded. Heterogeneity of data precluded meta-analysis. A total of 82 studies met inclusion criteria, and 253 discrete tumors were analyzed. A total of 23.4% of patients had von Hippel-Lindau disease. Von Hippel-Lindau-associated tumors affected females to males in a 2.4:1 ratio. Patients with von Hippel-Lindau disease displayed earlier average age at diagnosis compared to the sporadic cohort. Surgery was the primary treatment modality and was performed in 88.9% of cases. Adjuvant radiation therapy was employed in 18.7% of cases; 16.2% cases recurred, and 10.6% had progression of residual disease after treatment. Mean time to recurrence or progression was 53.1 ± 52.4 months with a range of 3 to 240 months. Endolymphatic sac tumors require a high degree of suspicion for early diagnosis. Complete resection is the standard of care. No strong evidence supports routine use of adjuvant radiation therapy. Given the high rate of recurrence and wide-ranging time to recurrence, long-term follow-up is necessary.
Identifiants
pubmed: 35763364
doi: 10.1177/01945998221108313
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
282-290Informations de copyright
© 2022 American Academy of Otolaryngology-Head and Neck Surgery Foundation.
Références
Couloigner V, Teixeira M, Sterkers O, Rask-Andersen H, Ferrary E. The endolymphatic sac: its roles in the inner ear [in French]. Med Sci (Paris). 2004;20(3):304-310.
Lonser RR, Baggenstos M, Kim HJ, Butman JA, Vortmeyer AO. The vestibular aqueduct: site of origin of endolymphatic sac tumors. J Neurosurg. 2008;108(4):751-756.
Megerian CA, McKenna MJ, Nuss RC, et al. Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope. 1995;105(8I):801-808.
Zanoletti E, Girasoli L, Borsetto D, Opocher G, Mazzoni A, Martini A. Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies [in Italian]. Acta Otorhinolaryngol Ital. 2017;37(5):423-429.
Hassard AD, Boudreau SF, Cron CC. Adenoma of the endolymphatic sac. J Otolaryngol. 1984;13(4):213-216.
Gaffey MJ, Mills SE, Fechner RE, Intemann SR, Wick MR. Aggressive papillary middle-ear tumor: a clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol. 1988;12(10):790-797.
Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathologic study of 20 cases. Cancer. 1989;64(11):2292-2302.
Riggs WJ, Catalano DJ, Harris MS, Adunka OF, Moberly AC. Intraoperative electrocochleography: a window into endolymphatic hydrops in a patient with an endolymphatic sac tumor. Otol Neurotol. 2017;38(4):547-550.
Maher ER, Kaelin WG Jr. Von Hippel-Lindau disease. Medicine. 1997;76(6):381-391.
Tysome JR, Harcourt J, Patel MC, Sandison A, Michaels L. Aggressive papillary tumor of the middle ear: a true entity or an endolymphatic sac neoplasm? Ear Nose Throat J. 2008;87(7):378-393.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Military Med Res. 2020;7(1):7.
Munn Z, Barker TH, Moola S, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evidence Synthesis. 2020;18(10):2127-2133.
Bambakidis NC, Rodrigue T, Megerian CA, Ratcheson RA. Endolymphatic sac tumor metastatic to the spine. J Neurosurg Spine. 2005;3(1):68-70.
Tay KY, Yu E, Kassel E. Spinal metastasis from endolymphatic sac tumor. Am J Neuroradiol. 2007;28(4):613-614.
Kirsh ER, Kozin ED, Knoll RM, et al. Sequential imaging in patient with suspected Menière's disease identifies endolymphatic sac tumor. Otol Neurotol. 2018;39(9):e856-e859.
Butman JA, Kim HJ, Baggenstos M, et al. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease. JAMA. 2007;298(1):41-48.
Kim HJ, Hagan M, Butman JA, et al. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications. Laryngoscope. 2013;123(2):477-483.
Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease. JAMA. 1997;277(18):1461-1466.
Bambakidis NC, Megerian CA, Ratcheson RA. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol. 2004;25(5):773-781.
Mendenhall WM, Suárez C, Skálová A, et al. Current treatment of endolymphatic sac tumor of the temporal bone. Adv Ther. 2018;35(7):887-898.
Patel NP, Wiggins RH, Shelton C. The radiologic diagnosis of endolymphatic sac tumors. Laryngoscope. 2006;116(1):40-46.
Sykopetrites V, Piras G, Giannuzzi A, Caruso A, Taibah A, Sanna M. The endolymphatic sac tumor: challenges in the eradication of a localized disease. Eur Arch Otorhinolaryngol. 2021;278(7):2297-2304.
Schipper J, Maier W, Rosahl SK, et al. Endolymphatic sac tumours: surgical management. J Otolaryngol. 2006;35(6):387-394.
Poletti AM, Dubey SP, Barbò R, et al. Sporadic endolymphatic sac tumor: its clinical, radiological, and histological features, management, and follow-up. Head Neck. 2013;35(7):1043-1047.
Wick CC, Eivaz NA, Yeager LH, Hunter JB, Isaacson B, Kutz JW Jr. Case series and systematic review of radiation outcomes for endolymphatic sac tumors. Otol Neurotol. 2018;39(5):550-557.
Nelson T, Hu J, Bannykh S, Fan X, Rudnick J, Vail E. Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome. CNS Oncol. 2020;9(1):Cns50.
Nevoux J, Nowak C, Vellin JF, et al. Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease. Otol Neurotol. 2014;35(5):899-904.
Bae SH, Kim SS, Kwak SH, Jung JS, Choi JY, Moon IS. Clinical features and treatment of endolymphatic sac tumor. Acta Otolaryngol. 2020;140(6):433-437.
Benecke JE Jr , Noel FL, Carberry JN, House JW, Patterson M. Adenomatous tumors of the middle ear and mastoid. Am J Otol. 1990;11(1):20-26.
Carlson ML, Thom JJ, Driscoll CL, et al. Management of primary and recurrent endolymphatic sac tumors. Otol Neurotol. 2013;34(5):939-943.
Guo F, Zhang L, Mo L. Long experience for the diagnosis and treatment of sporadic endolymphatic sac tumor in a single center. Clin Neurol Neurosurg. 2020;197:106078.
Hansen MR, Luxford WM. Surgical outcomes in patients with endolymphatic sac tumors. Laryngoscope. 2004;114(8I):1470-1474.
Hou Z-H, Huang D-L, Han D-Y, Dai P, Young W-Y, Yang S-M. Surgical treatment of endolymphatic sac tumor. Acta Otolaryngol. 2012;132(3):329-336.
Husseini ST, Piccirillo E, Taibah A, Paties CT, Almutair T, Sanna M. The Gruppo Otologico experience of endolymphatic sac tumor. Auris Nasus Larynx. 2013;40(1):25-31.
Kim HJ, Butman JA, Brewer C, et al. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg. 2005;102(3):503-512.
Li JC, Brackmann DE, Lo WW, Carberry JN, House JW. Reclassification of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumors. Laryngoscope. 1993;103(12):1342-1348.
Li F, Zhang Y, Li W, et al. Grading system and surgical approaches for endolymphatic sac tumors. Eur Arch Otorhinolaryngol. 2021;278(5):1345-1353.
Megerian CA, Haynes DS, Poe DS, Choo DI, Keriakas TJ, Glasscock IME. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol. 2002;23(3):378-387.
Rodrigues S, Fagan P, Turner J. Endolymphatic sac tumors: a review of the St. Vincent's Hospital experience. Otol Neurotol. 2004;25(4):599-603.
Timmer FC, Neeskens LJ, van den Hoogen FJ, et al. Endolymphatic sac tumors: clinical outcome and management in a series of 9 cases. Otol Neurotol. 2011;32(4):680-685.